China Anti-Obesity Drug Market: Segmented by Drug type (Prescription and OTC), Distribution channels (Hospital Pharmacies, Retail pharmacies and E-pharmacies)- Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139831
- Pages: 200
-
Format:
Report Overview
The China Anti-obesity drug market size stood at around USD 0.90 billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The Covid 19 pandemic has affected the growth of Anti-obesity drugs in china. It has incubated a sedentary lifestyle among the population to practice social distancing and sever lockdowns. The healthcare organization has issued a guideline and recommendation for the management of overweight/ obese patients as they have the greater probability of contracting the disease.
Market Drivers
Increasing prevalence of obesity is propelling the demand for these drugs in china. The growing awareness among the patient about the weight gains and associated impacts on other health disorders is attracting the patients towards this medication. The increasing adoption of a sedentary lifestyle and unhealthy diet plans along with the lack of exercise has led to increased body weight and adoption of anti-obesity drugs. The lack of weight management among th people and false mindsets of the people are the two factors restraining the growth of these market
1. China Anti-Obesity Drug Market Overview..................................................
A. Market Size
2. Market Growth Drivers..................................................................................
A. Growing prevalence of cardiovascular diseases and associated health disorders
B. Sedentary lifestyle and unhealthy diet plans
3. Mechanism of Action..........................................................................................
A. Peripherally acting
B. Centrally acting
4. Anti-Obesity drug Market Segmentation........................................................
A. Drug type
I. OTC
II. Prescription
B. Distribution channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. E-Pharmacies
C. Drug class
I. Orlistat
II. Certilistat
III. Lorcaserin
IV. Sibutramine
V. Rimonabant
VI. Metformin
VII. Exenatide
VIII. Amylin
IX. Topiramate
X. Bupropion
XI. Others
5. Anti-Obesity Drugs Major Products Market Share.......................................
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape......................................................................................
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..........................................................................................
A. GSK Company overview, Product & Services, Strategies & Financials
B. Novo Nordisk Company overview, Product & Services, Strategies & Financials
C. Pfizer Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.............................................
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth............................................................................
A. New Trends and Development of Anti-Obesity Drug market
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
